• OPEN AN ACCOUNT
Indian Indices
Sensex
81,537.70 -769.67
( -0.94%)
Global Indices
Nasdaq
49,128.98 -276.04
(-0.56%)
Dow Jones
6,938.97 4.62
(0.07%)
Hang Seng
53,831.56 142.67
(0.27%)
Nikkei 225
10,138.52 -11.53
(-0.11%)
Forex
USD-INR
91.58 0.09
(0.10%)
EUR-INR
107.27 0.14
(0.13%)
GBP-INR
123.20 0.33
(0.27%)
JPY-INR
0.58 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
39.16
773.38
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.23
 

prime fresh limited
Fitch Ratings affirms ratings of UltraTech Cement at 'BBB-'
Nov 19,2025

Fitch Ratings stated that the ratings incorporate the agency’s expectation of a modest leverage profile, with EBITDA net leverage sustained around 1.5x; a leading market position in India; a large market with robust long term demand-growth potential; and cost-efficient operations.

The agency further said that factors that could, individually or collectively, lead to positive rating action/upgrade include EBITDA net leverage below 1.5x on a sustained basis; improved business mix, with segments other than grey cement contributing around 30% of revenue; expectations of neutral or positive FCF profile; and strengthening of Grasim's consolidated credit profile.

However, a worsening market position or industry competitive environment that causes a sustained deterioration in the unit EBITDA margin; an EBITDA net leverage sustained above 2.5x; or a weakening of Grasim's consolidated credit profile could lead to a negative rating action or downgrade.

UltraTech Cement is the cement flagship company of the Aditya Birla Group. It is the third-largest cement producer in the world, outside of China, with a consolidated grey cement capacity of 154.86 MTPA.

The cement major reported a 75.23% year-on-year (YoY) rise in consolidated net profit to Rs 1,231.58 crore for Q2 FY26, with revenue from operations growing 20.33% YoY to Rs 19,606.93 crore.

The scrip was down 0.05% to currently trade at Rs 11701 on the BSE.